Mitral Regurgitation Treatment in Advanced Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 172 participants.

Also called NCT05292716

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 172 participants (planned count) (from the registry)
Sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (from the registry)
Registry
  • NCT NCT05292716
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05292716. Randomized; no masking; primary purpose other. Start 2021-04-21 (actual); primary completion 2025-04-21 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Mitral Regurgitation Treatment in Advanced Heart Failure
Acronym
MITRADVANCE
Condition
Heart Failure
Condition
Mitral Regurgitation
Intervention (Device)
MitraClip
Lead sponsor
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (class: other)

Record details

Record id
cardio:ct-nct05292716
Content hash
636b2810f3f95f38536869dfa1f4c8f9584a6a4c881beeea5bfe3ba2b7af6611